Steve Pakola

Insider Reports History

Entity
Individual
Location
C/O Regenxbio Inc., 9804 Medical Center Drive, Rockville, MD
Signature
/s/ Patrick J. Christmas as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steve Pakola:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENXBIO Inc. Chief Medical Officer Common Stock 216K $1.67M $7.73 Jan 2, 2025 Direct
REGENXBIO Inc. Chief Medical Officer Stock Options (Right to buy) 104K Jan 2, 2025 Direct
REGENXBIO Inc. Chief Medical Officer Stock Options (Right to Buy) 31.3K Mar 5, 2024 Direct

Insider Reports Filed by Steve Pakola

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RGNX REGENXBIO Inc. Jan 2, 2025 3 -$107K 4 Jan 6, 2025 Chief Medical Officer
RGNX REGENXBIO Inc. Aug 1, 2024 1 $0 4 Aug 5, 2024 Chief Medical Officer
RGNX REGENXBIO Inc. Mar 5, 2024 3 -$78.7K 4 Mar 7, 2024 Chief Medical Officer
RGNX REGENXBIO Inc. Jan 2, 2024 4 -$486K 4 Jan 4, 2024 Chief Medical Officer
RGNX REGENXBIO Inc. Jan 3, 2023 4 -$111K 4 Jan 5, 2023 Chief Medical Officer
RGNX REGENXBIO Inc. Jan 1, 2022 4 -$91.6K 4 Jan 4, 2022 Chief Medical Officer